Proof of Concept Study to Isolate Cosmetic Improvement of Skin Using the Vitro Biopharma Secretome/Exosome Serum
Part of paid clinical trials in Chestnut Hill, Massachusetts.
- Sponsor
- Vitro Biopharma Inc.
- Study ID
- NCT07620158
- Status
- Completed
Conditions
- Cosmetic Effect
Eligibility Criteria
- Sex
- ALL
- Age
- 30 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Secretome/Exosome Serum — OTHERThe Vitro Biopharma Exosome Serum contains extracellular vesicles derived from umbilical cord MSCs
Study Details
The purpose of this research is to characterize the safety, tolerability and efficacy of the investigational topical cosmetic product, the Vitro Biopharma Exosome Serum (Intervention), in impacting the cosmetic appearance of skin along with a microneedling procedure.
Key Dates
- Start date
- Apr 17, 2024
- Status verified
- May 2026
- Primary completion
- Jan 30, 2025
- Completion
- Jan 30, 2025
Study Design
- Enrollment
- 7 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Intervention v Control
Primary Outcome Measure
Number of Participants with Procedure-Related Adverse Events by Symptom and Severity [ Time Frame: Procedure Day through Day 90 follow-up (assessments at 1 hour, Day 1, 7, 21, 45, 46, 52, 66, and 90) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Skincare Physicians | Chestnut Hill | Massachusetts | 02467 | - |
Find similar trials in Chestnut Hill, MA
By research site